Vitalhub (TSE:VHI - Get Free Report) had its price objective upped by equities researchers at Canaccord Genuity Group from C$12.00 to C$12.50 in a research note issued on Thursday,BayStreet.CA reports. The firm presently has a "buy" rating on the stock. Canaccord Genuity Group's price objective suggests a potential upside of 12.31% from the company's previous close.
A number of other research analysts have also weighed in on the company. TD Securities raised Vitalhub to a "strong-buy" rating in a report on Monday, November 25th. Cormark upped their target price on Vitalhub from C$9.50 to C$10.50 and gave the company a "buy" rating in a research report on Wednesday, October 2nd. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Vitalhub currently has a consensus rating of "Buy" and an average price target of C$10.05.
Check Out Our Latest Stock Report on VHI
Vitalhub Stock Performance
Shares of TSE VHI traded up C$0.18 during mid-day trading on Thursday, hitting C$11.13. The stock had a trading volume of 84,818 shares, compared to its average volume of 132,559. The firm has a market cap of C$565.96 million, a PE ratio of 101.18, a PEG ratio of 1.18 and a beta of 1.26. The company has a 50 day moving average of C$11.11 and a two-hundred day moving average of C$9.38. Vitalhub has a twelve month low of C$4.00 and a twelve month high of C$12.09.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
